| The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings RW Paterson, RL Brown, L Benjamin, R Nortley, S Wiethoff, T Bharucha, ... Brain 143 (10), 3104-3120, 2020 | 1221 | 2020 |
| Shift toward prior knowledge confers a perceptual advantage in early psychosis and psychosis-prone healthy individuals C Teufel, N Subramaniam, V Dobler, J Perez, J Finnemann, PR Mehta, ... Proceedings of the National Academy of Sciences 112 (43), 13401-13406, 2015 | 285 | 2015 |
| COVID-19, SARS and MERS: a neurological perspective KCNK Kwong, PR Mehta, G Shukla, AR Mehta Journal of Clinical Neuroscience 77, 13-16, 2020 | 204 | 2020 |
| Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study RJ Perry, A Tamborska, B Singh, B Craven, R Marigold, P Arthur-Farraj, ... The Lancet 398 (10306), 1147-1156, 2021 | 178 | 2021 |
| Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination–A report of two UK cases PR Mehta, SA Mangion, M Benger, BR Stanton, J Czuprynska, R Arya, ... Brain, behavior, and immunity 95, 514-517, 2021 | 148 | 2021 |
| COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database RYS Keh, S Scanlon, P Datta-Nemdharry, K Donegan, S Cavanagh, ... Brain 146 (2), 739-748, 2023 | 74 | 2023 |
| Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial J Gold, DB Rowe, MC Kiernan, S Vucic, S Mathers, RPA van Eijk, A Nath, ... Amyotrophic lateral sclerosis and frontotemporal degeneration 20 (7-8), 595-604, 2019 | 71 | 2019 |
| Genotype, extrapyramidal features, and severity of variant ataxia‐telangiectasia K Schon, NJH van Os, N Oscroft, H Baxendale, D Scoffings, J Ray, M Suri, ... Annals of neurology 85 (2), 170-180, 2019 | 68 | 2019 |
| Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias PR Mehta, AR Jones, S Opie-Martin, A Shatunov, A Iacoangeli, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (3), 268-271, 2019 | 60 | 2019 |
| Resting state networks and memory consolidation NB Albert, EM Robertson, P Mehta, RC Miall Communicative & integrative biology 2 (6), 530-532, 2009 | 57 | 2009 |
| Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes RW Paterson, LA Benjamin, PR Mehta, RL Brown, D Athauda, NJ Ashton, ... Brain communications 3 (3), fcab099, 2021 | 48 | 2021 |
| The response of the tandem pore potassium channel TASK‐3 (K2P9.1) to voltage: gating at the cytoplasmic mouth I Ashmole, DV Vavoulis, PJ Stansfeld, PR Mehta, JF Feng, MJ Sutcliffe, ... The Journal of Physiology 587 (20), 4769-4783, 2009 | 42 | 2009 |
| Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD S Seddighi, YA Qi, AL Brown, OG Wilkins, C Bereda, C Belair, YJ Zhang, ... Science Translational Medicine 16 (734), eadg7162, 2024 | 39 | 2024 |
| Amyloid processing in COVID‐19‐associated neurological syndromes OJ Ziff, NJ Ashton, PR Mehta, R Brown, D Athauda, J Heaney, ... Journal of neurochemistry 161 (2), 146-157, 2022 | 39 | 2022 |
| Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy M Garcia-Montojo, S Fathi, G Norato, BR Smith, DB Rowe, MC Kiernan, ... Journal of the neurological sciences 423, 117358, 2021 | 35 | 2021 |
| Predicting the future of ALS: the impact of demographic change and potential new treatments on the prevalence of ALS in the United Kingdom, 2020–2116 A Gowland, S Opie-Martin, KM Scott, AR Jones, PR Mehta, CJ Batts, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20 (3-4), 264-274, 2019 | 32 | 2019 |
| The era of cryptic exons: implications for ALS-FTD PR Mehta, AL Brown, ME Ward, P Fratta Molecular Neurodegeneration 18 (1), 16, 2023 | 25 | 2023 |
| The impact of age on genetic testing decisions in amyotrophic lateral sclerosis PR Mehta, A Iacoangeli, S Opie-Martin, JJFA van Vugt, A Al Khleifat, ... Brain 145 (12), 4440-4447, 2022 | 24 | 2022 |
| Antiphospholipid antibodies and neurological manifestations in acute COVID-19: a single-centre cross-sectional study LA Benjamin, RW Paterson, R Moll, C Pericleous, R Brown, PR Mehta, ... EClinicalMedicine 39, 2021 | 24 | 2021 |
| The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration S Opie-Martin, A Iacoangeli, SD Topp, O Abel, K Mayl, PR Mehta, ... Nature communications 13 (1), 6901, 2022 | 20 | 2022 |
Arpan MehtaMRC Protein Phosphorylation & Ubiquitylation Unit, School of Life Sciences, University of DundeeVerified email at dundee.ac.uk
